Results 291 to 300 of about 141,551 (313)

Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma

Molecular Therapy - Oncolytics, 2021
Xiwang Zheng, Wei Gao, Binquan Wang
exaly  

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Ca-A Cancer Journal for Clinicians, 2015
Angela C Chi, Brad W Neville
exaly  

Squamous cell carcinoma of the head and neck: past progress and future promise

Ca-A Cancer Journal for Clinicians, 1998
Helmuth Goepfert
exaly  

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Annals of Oncology, 2012
R Hitt, A Irigoyen, H Cortes-Funes
exaly  

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Annals of Oncology, 2018
Jean-Pascal Machiels, Paolo Bossi, Jessica Menis   +2 more
exaly  

MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)

Cancers, 2010
Masashi Shiiba, Katsuhiro Uzawa, Shiiba Masashi   +2 more
exaly  

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Lancet, The, 2019
Ezra Cohen, Jonathan Cheng, Mirelis Acosta-Rivera   +2 more
exaly  

Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer

Ca-A Cancer Journal for Clinicians, 2008
Everett E Vokes
exaly  

Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary

Annals of Oncology, 2003
Athanassios Argiris, S M Smith, Merrill S Kies   +2 more
exaly  

DNA methylation biomarkers for head and neck squamous cell carcinoma

Epigenetics, 2018
Chongchang Zhou, Meng Ye, Qun Li
exaly